References
- Schuler Iv CF, Montejo JM. Allergic rhinitis in children and adolescents. Pediatr Clin North Am. 2019;66(5):981–993. doi: 10.1016/j.pcl.2019.06.004
- Bousquet J, Anto JM, Bachert C, et al. Allergic rhinitis. Nat Rev Dis Primers. 2020;6(1):95. doi: 10.1038/s41572-020-00227-0
- Zhang Y, Lan F, Zhang L. Advances and highlights in allergic rhinitis. Allergy. 2021;76(11):3383–3389. doi: 10.1111/all.15044
- Agnihotri NT, McGrath KG. Allergic and nonallergic rhinitis. Allergy Asthma Proc. 2019;40(6):376–379. doi: 10.2500/aap.2019.40.4251
- Campo P, Eguiluz‐Gracia I, Bogas G, et al. Local allergic rhinitis: implications for management. Clin Exp Allergy. 2019;49(1):6–16. doi: 10.1111/cea.13192
- Meng Y, Wang C, Zhang L. Advances and novel developments in allergic rhinitis. Allergy. 2020;75(12):3069–3076. doi: 10.1111/all.14586
- Nappi E, Paoletti G, Malvezzi L, et al. Comorbid allergic rhinitis and asthma: important clinical considerations. Expert Rev Clin Immunol. 2022;18(7):747–758. doi: 10.1080/1744666X.2022.2089654
- Zhang Y, Lan F, Zhang L. Update on pathomechanisms and treatments in allergic rhinitis. Allergy. 2022;77(11):3309–3319. doi: 10.1111/all.15454
- Pu X, Wang X, Chen Y, et al. Application of proteomics in allergic rhinitis.Jou of Clini Otolary Head and Neck Sur. 2022;36(2):153–157. doi: 10.13201/j.issn.2096-7993.2022.02.017
- Chen W, Yang A, Jia J, et al. Lysyl oxidase (LOX) family members: rationale and their potential as therapeutic targets for liver fibrosis. Hepatology. 2020;72(2):729–741. doi: 10.1002/hep.31236
- Khan H, Zafar M, Den-Haan H, et al. In-silico Studies of Isolated Phytoalkaloid Against Lipoxygenase: Study Based on Possible Correlation. Comb Chem High Throughput Screen. 2018;21(3):215–221. doi: 10.2174/1386207321666180220125406
- Aparoy P, Reddy KK, Reddanna P. Structure and ligand based drug design strategies in the development of novel 5- LOX inhibitors. Curr Med Chem. 2012;19(22):3763–3778. doi: 10.2174/092986712801661112
- Wang W, Wang X, Yao F, et al. Lysyl oxidase family proteins: prospective therapeutic targets in cancer. Int J Mol Sci. 2022;23(20):23(20. doi: 10.3390/ijms232012270
- Johnston KA, Lopez KM. Lysyl oxidase in cancer inhibition and metastasis. Cancer Lett. 2018;417:174–181. doi: 10.1016/j.canlet.2018.01.006
- Ma L, Song H, Zhang M, et al. Lysyl oxidase G473A polymorphism is associated with increased risk of coronary artery diseases. DNA Cell Biol. 2011;30(12):1033–1037. doi: 10.1089/dna.2011.1261
- Wu J, Cai C, Tong D, et al. Lysyl oxidase G473A polymorphism is associated with increased risk of ovarian cancer. Genet Test Mol Biomarkers. 2012;16(8):915–919. doi: 10.1089/gtmb.2011.0374
- Zhang H-F, Zhao K-J, Xu Y, et al. Lysyl oxidase polymorphisms and ischemic stroke—a case control study. Mol Biol Rep. 2012;39(10):9391–9397. doi: 10.1007/s11033-012-1803-9
- Nayak A, Langdon RB. Montelukast in the treatment of allergic rhinitis: an evidence-based review. Drugs. 2007;67(6):887–901. doi: 10.2165/00003495-200767060-00005
- Yilmaz O, Altintas D, Rondon C, et al. Effectiveness of montelukast in pediatric patients with allergic rhinitis. Int J Pediatr Otorhinolaryngol. 2013;77(12):1922–1924. doi: 10.1016/j.ijporl.2013.10.006
- Scadding GK, Kariyawasam HH, Scadding G, et al. BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (revised edition 2017; first edition 2007). Clin Experimental Allergy. 2017;47(7):856–889. doi: 10.1111/cea.12953
- Brown T. Diagnosis and management of allergic rhinitis in children. Pediatr Ann. 2019;48(12):e485–e488. doi: 10.3928/19382359-20191111-01
- Klimek L, Sperl A, Becker S, et al. Current therapeutical strategies for allergic rhinitis. Expert Opin Pharmacother. 2019;20(1):83–89. doi: 10.1080/14656566.2018.1543401
- Mukherjee S, Katarkar A, Dhariwal R, et al. Effect of Lysyl oxidase G473 a polymorphism on Lysyl oxidase and total Soluble collagen Expression in oral submucous fibrosis. Asian Pac J Cancer Prev. 2021;22(8):2493–2499. doi: 10.31557/APJCP.2021.22.8.2493
- Min C, Yu Z, Kirsch KH, et al. A loss-of-function polymorphism in the propeptide domain of the LOX gene and breast cancer. Cancer Res. 2009;69(16):6685–6693. doi: 10.1158/0008-5472.CAN-08-4818
- Gao X, Zhang S, Zhu Z. Lysyl oxidase rs1800449 polymorphism and cancer risk among Asians: evidence from a meta-analysis and a case-control study of colorectal cancer. Mol Genet Genomics. 2015;290(1):23–28. doi: 10.1007/s00438-014-0896-3
- Ren J, Wu X, He W, et al. Lysyl oxidase 473 G>A polymorphism and breast cancer susceptibility in Chinese han population. DNA Cell Biol. 2011;30(2):111–116. doi: 10.1089/dna.2010.1098
- Zhang HF, Zhao K-J, Xu Y, et al. Lysyl oxidase polymorphisms and ischemic stroke—a case control study. Mol Biol Rep. 2012;39(10):9391–9397. doi: 10.1007/s11033-012-1803-9
- Krishnamoorthy M, Noor NM, Lazim NM, et al. Efficacy of montelukast in allergic rhinitis treatment: a systematic review and meta-analysis. Drugs. 2020;80(17):1831–1851. doi: 10.1007/s40265-020-01406-9